{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T02:29:38Z","timestamp":1788661778249,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.vascn.2005.02.003","type":"journal-article","created":{"date-parts":[[2005,4,8]],"date-time":"2005-04-08T09:19:02Z","timestamp":1112951942000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["A novel predictive pharmacokinetic\/pharmacodynamic model of repolarization prolongation derived from the effects of terfenadine, cisapride and E-4031 in the conscious chronic av node\u2014ablated, His bundle-paced dog"],"prefix":"10.1016","volume":"53","author":[{"given":"Emily R.","family":"Nolan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihua Rose","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Koup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Turluck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome B.","family":"Paulissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Bari","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc B.","family":"Bailie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2005.02.003_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jelectrocard.2004.08.004","article-title":"Arrhythmogenic mechanisms of QT prolonging drugs: Is QT prolongation really the problem?","volume":"37","author":"Antzelevitch","year":"2004","journal-title":"Journal of Electrocardiology"},{"key":"10.1016\/j.vascn.2005.02.003_bib2","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.1540-8159.1999.tb00635.x","article-title":"Comparison of formulae for heart rate correction of QT interval in exercise electrocardiograms","volume":"22","author":"Aytemir","year":"1999","journal-title":"Pacing and Clinical Electrophysiology"},{"key":"10.1016\/j.vascn.2005.02.003_bib3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/hrt.55.3.253","article-title":"Diurnal variation of the QT interval\u2014influence of the autonomic nervous system","volume":"55","author":"Bexton","year":"1986","journal-title":"British Heart Journal"},{"issue":"1","key":"10.1016\/j.vascn.2005.02.003_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0167-5273(97)00331-8","article-title":"Idiopathic long QT syndrome with late onset of bradycardia-dependent and short-coupled variant of torsade de pointes","volume":"64","author":"Chiladakis","year":"1998","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.vascn.2005.02.003_bib5","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1124\/jpet.102.035220","article-title":"The relationship of clinical QT prolongation to outcome in the conscious dog using a beat-to-beat QT\u2013RR interval assessment","volume":"202","author":"Fossa","year":"2002","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2005.02.003_bib6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejphar.2003.12.028","article-title":"Differential effect of HERG blocking agents on cardiac electrical alternans in the guinea pig","volume":"486","author":"Fossa","year":"2004","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2005.02.003_bib7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00005344-199423030-00003","article-title":"Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias","volume":"23","author":"Fujiki","year":"1994","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"6","key":"10.1016\/j.vascn.2005.02.003_bib8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/clpt.1991.206","article-title":"Pharmacokinetics and pharmacodynamics of cisapride in patients undergoing hemodialysis","volume":"50","author":"Gladziwa","year":"1991","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"Supplement 1","key":"10.1016\/j.vascn.2005.02.003_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00002018-199921001-00006","article-title":"Effects of H1 antihistamines on animal models of QTc prolongation","volume":"21","author":"Gras","year":"1999","journal-title":"Drug Safety"},{"key":"10.1016\/j.vascn.2005.02.003_bib10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2125.1981.tb01123.x","article-title":"The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals: Concentration\u2014effects relationships","volume":"11","author":"Holford","year":"1981","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.vascn.2005.02.003_bib11","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1161\/01.CIR.103.15.2004","article-title":"Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic","volume":"103","author":"Hondeghem","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2005.02.003_bib12","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/jama.1993.03500120051025","article-title":"Terfenadine\u2013ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences","volume":"269","author":"Honig","year":"1993","journal-title":"Journal of the American Medical Association"},{"issue":"1","key":"10.1016\/j.vascn.2005.02.003_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF02691087","article-title":"Heart rate\u2014QT relationships during baroreceptor stimulation with diminished autonomic influence on the ventricles","volume":"27","author":"Huang","year":"1992","journal-title":"Integrative Physiological and Behavioral Science"},{"issue":"3","key":"10.1016\/j.vascn.2005.02.003_bib14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1542-474X.2004.93533.x","article-title":"Brugada and long QT-3 syndromes: Two phenotypes of the sodium channel disease","volume":"9","author":"Khan","year":"2004","journal-title":"Annals of Noninvasive Electrocardiology"},{"key":"10.1016\/j.vascn.2005.02.003_bib15","first-page":"S807","article-title":"Electrocardiographic effects of mizolastine and terfenadine in conscious dogs","volume":"26","author":"Lainee","year":"1998","journal-title":"Japanese Pharmacology & Therapeutics"},{"key":"10.1016\/j.vascn.2005.02.003_bib16","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/S0735-1097(02)01852-1","article-title":"Autonomic nervous system influences on QT interval in normal subjects","volume":"39","author":"Magnano","year":"2002","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.vascn.2005.02.003_bib17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1046\/j.1540-8167.2001.00411.x","article-title":"Problems of heart rate correction in assessment of drug-induced QT interval prolongation","volume":"12","author":"Malik","year":"2001","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.vascn.2005.02.003_bib18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1460-9592.2002.00209.x","article-title":"The imprecision in heart rate correction may lead to artificial observations of drug induced QT interval changes","volume":"25","author":"Malik","year":"2002","journal-title":"Pacing and Clinical Electrophysiology"},{"key":"10.1016\/j.vascn.2005.02.003_bib19","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2165\/00003495-199039040-00006","article-title":"Terfenadine\u2014An updated review of its pharmacological properties and therapeutic efficacy","volume":"39","author":"McTavish","year":"1990","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.vascn.2005.02.003_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/00003088-200039010-00004","article-title":"Drug interactions with cisapride. Clinical implications","volume":"39","author":"Michalets","year":"2000","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.vascn.2005.02.003_bib21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1023\/A:1014460404352","article-title":"Quantitative relationship between myocardial concentration of tacrolimus and QT prolongation in guinea pigs: Pharmacodynamic model incorporating a site of adverse effect","volume":"6","author":"Minematsu","year":"2001","journal-title":"Journal of Pharmacokinetics and Pharmacodynamics"},{"key":"10.1016\/j.vascn.2005.02.003_bib22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/00005344-199511000-00013","article-title":"Terfenadine blocks time-dependent Ca2+, Na+ and K+ channels in guinea pig ventricular myocytes","volume":"26","author":"Ming","year":"1995","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.vascn.2005.02.003_bib23","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1046\/j.1540-8167.2003.03215.x","article-title":"Atrioventricular nodal ablation and His-Bundle pacing: An acute model for proarrhythmic risk assessment","volume":"14","author":"Olivier","year":"2003","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.vascn.2005.02.003_bib24","series-title":"Myocardial Repolarization","first-page":"151","author":"Oto","year":"2001"},{"key":"10.1016\/j.vascn.2005.02.003_bib25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and Torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern","year":"2003","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.vascn.2005.02.003_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1472-8206.2002.00098.x","article-title":"Safety pharmacology\u2014A progressive approach","volume":"16","author":"Redfern","year":"2002","journal-title":"Fundamental and Clinical Pharmacology"},{"issue":"10","key":"10.1016\/j.vascn.2005.02.003_bib27","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"Roden","year":"2004","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.vascn.2005.02.003_bib28","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/j.1540-8159.2004.00664.x","article-title":"Stability of ventricular repolarization in conscious dogs with chronic atrioventricular dissociation and His-Bundle pacing","volume":"27","author":"Sanders","year":"2004","journal-title":"Pacing and Clinical Electrophysiology"},{"key":"10.1016\/j.vascn.2005.02.003_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF01744586","article-title":"Simultaneous assessment of the hemodynamic, cardiomechanical, and electrophysiological effects of terfenadine on the in vivo canine model","volume":"13","author":"Usui","year":"1998","journal-title":"Heart and Vessels"},{"key":"10.1016\/j.vascn.2005.02.003_bib30","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0009-9236(98)90137-0","article-title":"The influence of cisapride and clarithromycin on QT intervals in healthy volunteers","volume":"64","author":"Van Haarst","year":"1998","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.vascn.2005.02.003_bib31","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/00498250110054632","article-title":"Pharmacokinetic\/pharmacodynamic assessment of the effects of E4031, cisapride, terfenadine and terodiline on monophasic action potential duration in dog","volume":"31","author":"Webster","year":"2001","journal-title":"Xenobiotica"},{"issue":"2","key":"10.1016\/j.vascn.2005.02.003_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00045391-200103000-00006","article-title":"Influence of electrolyte abnormalities on interlead variability of ventricular repolarization times in 12-lead electrocardiography","volume":"8","author":"Yelamanchi","year":"2001","journal-title":"American Journal of Therapeutics"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871905000225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871905000225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T23:50:46Z","timestamp":1761004246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871905000225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S1056871905000225"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2005.02.003","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel predictive pharmacokinetic\/pharmacodynamic model of repolarization prolongation derived from the effects of terfenadine, cisapride and E-4031 in the conscious chronic av node\u2014ablated, His bundle-paced dog","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2005.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}